Results 361 to 370 of about 681,261 (380)

Activating effect of the plasminogen activators on plasminogens of different mammalia species

Thrombosis Research, 1995
Abstract Plasmin (E.C. 3.4.21.7.) is a major serine proteolytic enzyme responsible for fibrinolytic function in mammalia blood plasma. It is formed by activation of proenzyme plasminogen with the known activators such as urokinase (UK, E.C. 3.4.21.31.), tissue-type plasminogen activator (t-PA, E.C. 3.4.21.67.) or streptokinase (SK) (1, 2).
Michail V. Rublenko, Sergey A. Yakovlev, Vitaliy I. Izdepsky, Eugeni M. Makogonenko   +3 more
openaire   +3 more sources

A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissuetype plasminogen activator (t-PA)

Blood Coagulation & Fibrinolysis, 1992
The earliest tissue plasminogen activator (t-PA) preparations prepared from melanoma cells were expressed in urinary-type plasminogen activator (u-PA) units of activity using the u-PA International Standard (66/46). This report describes a comparison between u-PA and t-PA units by various types of fibrin plate procedure using both human and bovine ...
P. J. Gaffney, L. J. Creighton-Kempsford, J. B. Pring   +2 more
openaire   +3 more sources

Effects of Fluvastatin and Bezafibrate Combination on Plasma Fibrinogen, t-plasminogen Activator Inhibitor and C Reactive Protein Levels in Coronary Artery Disease Patients with Mixed Hyperlipidaemia (FACT Study)

Thrombosis and Haemostasis, 2000
Michele Cortellaro, Elisabetta Cofrancesco, Carla Boschetti, F. Cortellaro, Marcello Mancini, Mario Mariani, Rodolfo Paoletti   +6 more
semanticscholar   +1 more source

Effects of Fluvastatin and Bezafibrate Combination on Plasma Fibrinogen, t-Plasminogen Activator Inhibitor and C Reactive Protein Levels in Coronary Artery Disease Patients with Mixed Hyperlipidaemia (FACT Study) – A Rebuttal

Thrombosis and Haemostasis, 2001
G. Hirschfield
semanticscholar   +1 more source

t-Plasminogen activator and von Willebrand factor in patients with unstable angina.

International Journal of Cardiology, 1996
D. Tousoulis, E. Bosinakou, C. Tentolouris, T. Apostolopoulos, C. Copshari, M. Kyriakides, P. Toutouzas   +6 more
semanticscholar   +1 more source

Effect of fluvastatin and bezafibrate combination on plasma levels of fibrinogen, t-plasminogen activator, PAI-1 and C reactive protein in coronary artery disease patients with combined hyperlipidemia (fact study)

, 1999
M. Cortellaro, E. Cofrancesco, C. Boschetti, M. Mancini, M. Mariani, R. Paoletti   +5 more
semanticscholar   +1 more source

Plasminogen Activators and Plasminogen Activator Inhibitors in Neural Developmenta

Annals of the New York Academy of Sciences, 1992
Alphonse Krystosek, Susan Haffke, Nicholas W. Seeds, Steve Hayden, Paul G. McGuire, Shahla Verrall, Daniela Gadotti, Glenn C. Friedman, Kathy Christensen, Brenda Gardner   +9 more
openaire   +3 more sources

ACTIVATION OF PLASMINOGEN

Annals of the New York Academy of Sciences, 1957
openaire   +3 more sources

PLASMJN AND PLASMINOGEN ACTIVATORS: KINETICS, AND KINETICS OF PLASMINOGEN ACTIVATION

Annals of the New York Academy of Sciences, 1981
Kenneth C. Robbins, Louis Summaria, R C Wohl   +2 more
openaire   +3 more sources

Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation

European Journal of Heart Failure, 2014
Y. Borné, M. Persson, O. Melander, J. Smith, G. Engström   +4 more
semanticscholar   +1 more source